Editorial: Emerging molecular mechanisms in cardiovascular physiology and pathology.
作者信息
Warren Junco S, Johnson Daniel M, Paneni Francesco, Mathiyalagan Prabhu
机构信息
Virginia Tech Carilion, Roanoke, VA, United States.
School of Life, Health and Chemical Sciences, The Open University, Milton Keynes, United Kingdom.
出版信息
Front Physiol. 2024 Sep 10;15:1485595. doi: 10.3389/fphys.2024.1485595. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Emerging molecular mechanisms in cardiovascular physiology and pathology.社论：心血管生理学和病理学中的新兴分子机制
Front Physiol. 2024 Sep 10;15:1485595. doi: 10.3389/fphys.2024.1485595. eCollection 2024.
2
Inhibitory effect of microRNA-21 on pathways and mechanisms involved in cardiac fibrosis development.miRNA-21 对心脏纤维化发展相关通路和机制的抑制作用。
Ther Adv Cardiovasc Dis. 2024 Jan-Dec;18:17539447241253134. doi: 10.1177/17539447241253134.
3
Adipocyte-specific deletion of HuR induces spontaneous cardiac hypertrophy and fibrosis.脂肪细胞特异性敲除 HuR 诱导自发性心肌肥厚和纤维化。
Am J Physiol Heart Circ Physiol. 2021 Jul 1;321(1):H228-H241. doi: 10.1152/ajpheart.00957.2020. Epub 2021 May 21.
4
Morphological and Functional Remodeling of Vascular Endothelium in Cardiovascular Diseases.心血管疾病中血管内皮的形态和功能重塑。
Int J Mol Sci. 2023 Jan 19;24(3):1998. doi: 10.3390/ijms24031998.
5
Nitric oxide-mediated protein modification in cardiovascular physiology and pathology.一氧化氮介导热心血管生理学和病理学中的蛋白质修饰。
Proteomics Clin Appl. 2008 Jun;2(6):811-22. doi: 10.1002/prca.200780079.
6
MicroRNA-21 regulates peroxisome proliferator-activated receptor alpha, a molecular mechanism of cardiac pathology in Cardiorenal Syndrome Type 4.miRNA-21 调节过氧化物酶体增殖物激活受体 α，这是 4 型心肾综合征中心脏病理的分子机制。
Kidney Int. 2018 Feb;93(2):375-389. doi: 10.1016/j.kint.2017.05.014. Epub 2017 Jul 29.
7
A Clinical Perspective of Anti-Fibrotic Therapies for Cardiovascular Disease.心血管疾病抗纤维化治疗的临床视角
Front Pharmacol. 2017 Apr 6;8:186. doi: 10.3389/fphar.2017.00186. eCollection 2017.
8
Correlation between myocardial fibrosis and restrictive cardiac physiology in patients undergoing retransplantation.心肌纤维化与再次移植患者限制性心脏生理学之间的相关性。
Clin Transplant. 2013 Nov-Dec;27(6):E679-84. doi: 10.1111/ctr.12250. Epub 2013 Sep 19.
9
The Molecular Mechanisms of Defective Copper Metabolism in Diabetic Cardiomyopathy.糖尿病心肌病中铜代谢缺陷的分子机制。
Oxid Med Cell Longev. 2022 Oct 4;2022:5418376. doi: 10.1155/2022/5418376. eCollection 2022.
10
Cancer therapy-related cardiac dysfunction: is endothelial dysfunction at the heart of the matter?癌症治疗相关的心脏功能障碍：内皮功能障碍是问题的核心吗？
Clin Sci (Lond). 2021 Jun 25;135(12):1487-1503. doi: 10.1042/CS20210059.
本文引用的文献
1
Treatment with recombinant Sirt1 rewires the cardiac lipidome and rescues diabetes-related metabolic cardiomyopathy.用重组 Sirt1 治疗可重新构建心脏脂质组，并挽救与糖尿病相关的代谢性心肌病。
Cardiovasc Diabetol. 2023 Nov 13;22(1):312. doi: 10.1186/s12933-023-02057-2.
2
Single-cell transcriptomics for the assessment of cardiac disease.单细胞转录组学用于评估心脏疾病。
Nat Rev Cardiol. 2023 May;20(5):289-308. doi: 10.1038/s41569-022-00805-7. Epub 2022 Dec 20.
3
Extracellular SPARC increases cardiomyocyte contraction during health and disease.细胞外基质糖胺聚糖蛋白聚糖增加了健康和疾病状态中心肌细胞的收缩。
PLoS One. 2019 Apr 1;14(4):e0209534. doi: 10.1371/journal.pone.0209534. eCollection 2019.
4
Histone methyltransferase Smyd1 regulates mitochondrial energetics in the heart.组蛋白甲基转移酶 Smyd1 调节心脏中的线粒体能量代谢。
Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):E7871-E7880. doi: 10.1073/pnas.1800680115. Epub 2018 Jul 30.
5
FTO-Dependent N-Methyladenosine Regulates Cardiac Function During Remodeling and Repair.FTO 依赖性 N6-甲基腺苷调节重塑和修复过程中心脏功能。
Circulation. 2019 Jan 22;139(4):518-532. doi: 10.1161/CIRCULATIONAHA.118.033794.
Zotero 插件